(Q36391445)

13 August 2017

1 reference

title

Progress and regression within primary Sjögren's syndrome (English)

1 reference

13 August 2017

Manthorpe R

1

1 reference

13 August 2017

Bredberg A

series ordinal

2

1 reference

13 August 2017

Henriksson G

series ordinal

3

1 reference

13 August 2017

Larsson A

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Scandinavian Journal of Rheumatology

13 August 2017

published in

1 reference

13 August 2017

volume

35

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

1-6

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

13 August 2017

1 reference

The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Increased Risk of Lymphoma in Sicca Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Sjorgren's syndrome treated with bromhexine: a randomised clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Evidence for coxsackievirus infection in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Sjogren's syndrome and the danger model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Sjögren's syndrome: autoimmune epithelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740500537945

RETRACTED: Infliximab in patients with primary Sjögren's syndrome: a pilot study

21 January 2018

0 references

Identifiers

DOI

10.1080/03009740500537945

1 reference

release_eriqerhmzvfjxmntbf7t27td6e

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eriqerhmzvfjxmntbf7t27td6e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference